Cargando…

Early experiences with edoxaban for stroke prevention in atrial fibrillation in the Southeast Asia region

Edoxaban, a once-daily, direct-acting oral anticoagulant, is approved to prevent stroke or systemic embolism in non-valvular atrial fibrillation (NVAF) and treat venous thromboembolism. The clinical benefit of edoxaban for stroke prevention in Asian patients with NVAF has been demonstrated in clinic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Diaz, Alejandro Bimbo, Chow, Jeremy, Hoo, Fan Kee, Koh, Kok Wei, Lee, Gary Chin Keong, Teo, Wee Siong, Venketasubramanian, Narayanaswamy, Wang, Chun-Chieh, Mehta, Radhika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioExcel Publishing Ltd 2023
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499367/ https://www.ncbi.nlm.nih.gov/pubmed/37711730 http://dx.doi.org/10.7573/dic.2023-3-3

Ejemplares similares

Maternal, neonatal, and child health in southeast Asia: towards greater regional collaboration
por: Acuin, Cecilia S, et al.
Publicado: (2011)

The burden, risk factors and unique etiologies of stroke in South-East Asia Region (SEAR)
por: Pandian, Jeyaraj D., et al.
Publicado: (2023)

Is preprocedural imaging before radiofrequency catheter ablation of atrial fibrillation and image integration useless?
por: Teo, Wee Siong
Publicado: (2021)

Stroke Prevention in Atrial Fibrillation: Understanding the New Oral Anticoagulants Dabigatran, Rivaroxaban, and Apixaban
por: Ru San, Tan, et al.
Publicado: (2012)

2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation
por: Chiang, Chern-En, et al.
Publicado: (2017)

Factors Associated With Edoxaban Concentration Among Patients With Atrial Fibrillation
por: Lin, Shin-Yi, et al.
Publicado: (2021)

Cutaneous larva migrans: A One Health Perspective on Familial Infection Among Tourists Returning from Southeast Asia
por: Sałamatin, Rusłan, et al.
Publicado: (2023)

Tobacco control in Asia
por: Mackay, Judith, et al.
Publicado: (2013)

Edoxaban Monotherapy in Nonvalvular Atrial Fibrillation Patients with Coronary Artery Disease
por: Fukamachi, Daisuke, et al.
Publicado: (2022)

Southeast Asia
por: Warf, Barney
Publicado: (2017)

Clinical Events with Edoxaban in South Korean and Taiwanese Atrial Fibrillation Patients in Routine Clinical Practice
por: Choi, Eue-Keun, et al.
Publicado: (2021)

Epidemiology and Characteristics of Elizabethkingia spp. Infections in Southeast Asia
por: Zajmi, Asdren, et al.
Publicado: (2022)

An Overview of Whole Grain Regulations, Recommendations and Research across Southeast Asia
por: Brownlee, Iain A, et al.
Publicado: (2018)

Comparison of Once-Daily Administration of Edoxaban and Rivaroxaban in Asian Patients with Atrial Fibrillation
por: Lee, So-Ryoung, et al.
Publicado: (2019)

Outcomes of On-Label Reduced-Dose Edoxaban in Patients With Atrial Fibrillation: The LEDIOS Registry
por: Kim, Ju Youn, et al.
Publicado: (2022)

Hemoptysis in Quadriplegia with Atrial Fibrillation Who Was Taking Edoxaban: a Case Report
por: Jeong, Hoyoung, et al.
Publicado: (2021)

Stroke Epidemiology in South, East, and South-East Asia: A Review
por: Venketasubramanian, Narayanaswamy, et al.
Publicado: (2018)

Stroke Epidemiology in South, East, and South-East Asia: A Review
por: Venketasubramanian, Narayanaswamy, et al.
Publicado: (2017)

Haemoglobinopathies in Southeast Asia
por: Fucharoen, Suthat, et al.
Publicado: (2011)

Cost-Effectiveness of Anticoagulation in Patients with Nonvalvular Atrial Fibrillation with Edoxaban Compared to Warfarin in Germany
por: Krejczy, Martin, et al.
Publicado: (2015)

Cost-Effectiveness Analysis of Apixaban Versus Edoxaban in Patients with Atrial Fibrillation for Stroke Prevention
por: Oyagüez, Itziar, et al.
Publicado: (2019)

Plasma Concentration and Pharmacodynamics of Edoxaban in Patients with Nonvalvular Atrial Fibrillation and Acute Heart Failure
por: Nabeta, Takeru, et al.
Publicado: (2021)

Temperature is a regulator of leaf production in the family Dipterocarpaceae of equatorial Southeast Asia
por: Kobayashi, Masaki J., et al.
Publicado: (2020)

10th Anniversary of the Asia Pacific Stroke Organization: State of Stroke Care and Stroke Research in the Asia-Pacific
por: Tan, Kay-Sin, et al.
Publicado: (2021)

Surveillance of stroke: a South-East Asia Region (SEAR) perspective
por: Kalkonde, Yogeshwar V., et al.
Publicado: (2023)

Shorebirds wintering in Southeast Asia demonstrate trans-Himalayan flights
por: Li, David, et al.
Publicado: (2020)

Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe)
por: De Caterina, Raffaele, et al.
Publicado: (2019)

A Prospective Study to Evaluate the Effectiveness of Edoxaban for the Resolution of Left Atrial Thrombosis in Patients with Atrial Fibrillation
por: Patti, Giuseppe, et al.
Publicado: (2022)

On The Trail of Disease in Southeast Asia
por: Maxmen, Amy
Publicado: (2009)

Social structure in southeast Asia /
Publicado: (1960)

The cost of not breastfeeding in Southeast Asia
por: Walters, Dylan, et al.
Publicado: (2016)

The future of Southeast Asia’s forests
por: Estoque, Ronald C., et al.
Publicado: (2019)

Plantation Mapping in Southeast Asia
por: Jia, Xiaowei, et al.
Publicado: (2019)

Dementia in Southeast Asia: influence of onset-type, education, and cerebrovascular disease
por: Vipin, Ashwati, et al.
Publicado: (2021)

An evidence-based review of edoxaban and its role in stroke prevention in patients with nonvalvular atrial fibrillation
por: Acharya, Tushar, et al.
Publicado: (2015)

Edoxaban in Atrial Fibrillation and Venous Thromboembolism—Ten Key Questions and Answers: A Practical Guide
por: De Caterina, Raffaele, et al.
Publicado: (2017)

Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF–TIMI 48 Trial
por: Kato, Eri Toda, et al.
Publicado: (2016)

Edoxaban: A Comprehensive Review of the Pharmacology and Clinical Data for the Management of Atrial Fibrillation and Venous Thromboembolism
por: Stacy, Zachary A., et al.
Publicado: (2016)

Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial
por: Hohnloser, Stefan H, et al.
Publicado: (2019)

Edoxaban Versus Low-Molecular-Weight Heparin in Hospitalized COVID-19 Patients With Atrial Fibrillation
por: Olivera, Pável, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_525dfo7fnkf0jrrn789nhjc43v